From Niche to Necessary: Why the Longevity Brand Boom Is Just Getting Started

When you think about longevity, what comes to mind? Probably not a brand.

Peptides, molecules, biohacks. Billions are flowing into the next scientific breakthrough, and almost none of it into what actually connects science to daily life: building a strong brand. As Kara Swisher puts it, "Our lifespan is much longer than our health span. How can we bring those two together?" That's the brand question. The category hasn't answered it yet.

There are plenty of breakthroughs without brand names. The technology exists. People just don't feel like it's for them.

Twenty years ago, this is exactly how wellness arrived. A buzzword. A slightly cult-like fringe. Funding chasing something people couldn't quite define yet. And then, slowly and then all at once, an entire category that reshaped how people eat, move, sleep, and think about their bodies. Wellness entered everything. Beardwood was there at the beginning, from our brand transformation of Westin Hotels to our recent proprietary study on the Wellness Gap, and we're watching longevity follow the same arc.

The question is which brands will be standing on the other side of it. We have a point of view on that. We named Mitopure®, the ingredient brand for Urolithin A, and built Leap Years™, a cellular health system for pet longevity, both before their categories had names. What we learned still holds: the brands that break through don't lead with the molecule. They build the front door first and let the science earn trust once someone is already inside.

That's the insight the longevity category keeps missing. And GLP-1s are the proof.

What started as a diabetes treatment became the most culturally dominant health story of the last five years. The science was real, the results undeniable, but science alone doesn't move people. Ro figured that out early. They led with a human truth: this is harder than you've been told, and it's not your fault. Serena Williams put a face on it. She talked openly about struggling to lose post-baby weight despite doing everything right. Then, as the face of Abbott's Lingo glucose monitor, she shifted from that vulnerability to something more powerful: knowing my glucose means no more guessing. It's all based on data. My data.

She didn't sell a drug. She sold a version of herself that was winning on her own terms. That's the arc longevity brands need to learn to occupy.

Eli Lilly's Fundayo, the first FDA-approved daily GLP-1 pill, just expanded the audience further. Millions of Americans who won't take a shot will take a pill. Now they must grow a brand around it to invite people in.

When Beardwood worked with Danone to launch OIKOS Fusion, formulated to support muscle retention and digestion for people on GLP-1s, the challenge went beyond introducing a new product. It was building a brand that could live inside one of the most personal health journeys someone could be on. OIKOS Fusion needed to be a companion for the long haul and carve out a distinctive space in the brand’s existing portfolio. That's the kind of nuanced brief the longevity category needs more of to succeed.

Two million women enter perimenopause every year in the United States. That's not a niche. That's half the female population over 40: women running companies, training for marathons, holding themselves to standards the generation before them simply didn't have.

For decades, the category supposed to serve them was defined by clinical hesitancy and packaging designed to be hidden in a bathroom cabinet. Hot flash hype. Euphemistic language. Almost no real answers.

Women deserve better, and they're finally getting it.

Function Health is making comprehensive biomarker testing feel more accessible at a price point that used to require a concierge medicine budget. The real challenge isn't scientific. It's making an emotional connection. Function is leaning into a positioning of empowerment and taking ownership of your health, with a brand world that’s warm and soothing created to calm anxieties about testing results.

As Function grows, it can continue to borrow the playbook from outside the category.Data becomes a distinctive asset for Spotify Wrapped: taking invisible listening behavior into a cultural moment that people look forward to every December. Strava turned workout metrics into something athletes display like a badge, building a community where personal records become a shared celebration. Both took data that people didn't know they wanted to see and made it feel like identity.

Function is sitting on the same opportunity. Your biomarkers are already telling a story. The brand that helps people feel proud of knowing it and connected to others on the same journey.Knowing as power rather than anxiety. Progress can be created in the community.

Headspace cracked this in mental health, taking meditation mainstream. The science behind mindfulness was real, but Headspace led with a calmer, clearer, more yourself. They built educational courses with niche preferences to help you experience the progress. The science behind mindfulness feels more real once people are already committed to the ritual.

Longevity has the same opportunities and the same obstacles. Most people don't think about their mitochondria. They think about whether they'll keep up at work, stay active with their kids, or just feel like themselves at seventy-five. Build something human first to open the door. The brands that do that are the ones that cross from niche to necessary.